TABLE 2 .
Antibiotic resistance gene carriage in the placebo and erythromycin groups at baseline and at the end of erythromycin treatment (48 weeks)
| Resistance gene | % gene carriage in indicated group |
P value (Fisher's exact test, 48 wks) |
|||
|---|---|---|---|---|---|
| Placebo |
Erythromycin |
||||
| Baseline | 48 wks | Baseline | 48 wks | ||
| erm(A) | 2.4 | 2.4 | 4.7 | 4.7 | >0.99 |
| erm(B) | 53.6 | 56.1 | 60.5 | 69.8 | 0.26 |
| erm(C) | 17.1 | 12.2 | 11.6 | 14.0 | >0.99 |
| erm(F) | 53.6 | 48.8 | 41.9 | 44.2 | 0.82 |
| msrA | 0.0 | 2.4 | 0.0 | 0.0 | 0.49 |
| mef | 100.0 | 95.1 | 100.0 | 97.7 | 0.61 |